DRUGS MADE IN AMERICA ACQUIS
DMAA · NASDAQ
更新於 2026-10-14 09:06:44
$10.86+0.09%
- 今日最高
- $10.86
- 今日最低
- $10.84
%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23150%3B%26%23135%3B%26%23230%3B%26%23161%3B%26%23163%3B%26%23230%3B%26%23154%3B%26%23151%3B%26%23232%3B%26%23167%3B%26%23146%3B%22%20d%3D%22M48.3363%2013.4132H60.2082L46.795%205.72205e-06V11.8719C46.795%2012.7231%2047.4851%2013.4132%2048.3363%2013.4132Z%22%20fill%3D%22var(--fill-0%2C%20%23474741)%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23148%3B%26%23190%3B%26%23229%3B%26%23164%3B%26%23167%3B%26%23233%3B%26%23149%3B%26%23156%3B%22%20fill-rule%3D%22evenodd%22%20clip-rule%3D%22evenodd%22%20d%3D%22M11.3812%2020.3725C16.7977%2014.9559%2025.5803%2014.9559%2030.9969%2020.3725C36.413%2025.789%2036.4131%2034.5707%2030.9969%2039.9872C26.0109%2044.973%2018.1729%2045.3699%2012.7335%2041.1769L2.54298%2051.3684L0%2048.8254L10.1915%2038.6329C5.99993%2033.1937%206.39609%2025.3579%2011.3812%2020.3725ZM28.4539%2022.9155C24.4418%2018.9033%2017.9363%2018.9033%2013.9241%2022.9155C9.91245%2026.9275%209.91241%2033.4322%2013.9241%2037.4442C17.9362%2041.4562%2024.4418%2041.4562%2028.4539%2037.4442C32.4656%2033.4322%2032.4656%2026.9275%2028.4539%2022.9155Z%22%20fill%3D%22var(--fill-0%2C%20%235D5D56)%22%2F%3E%0A%3C%2Fg%3E%0A%20%20%3C%2Fsvg%3E%0A%3C%2Fsvg%3E%0A)
...
K線圖趨勢，實際資料以交易頁為準
關鍵數據
- 昨天開盤價
- $10.85
- 昨天收盤價
- $10.86
- 成交量
- 55.18K
- 市值
- $263.64M
- 市盈率（P/E）
- 43.25X
- 每股收益（EPS）
- $0.20
昨天價格區間
$10.84$10.86
52週價格區間
$10.26$10.89
公司概況
- 板塊
- 金融服務
- 行業
- N/A
- 子行業
- 空殼公司
- 總部
- 420 LEXINGTON AVENUE, NEW YORK, NY, UNITED STATES, 10170
- 國家
- 美國
- 上市日期
- 2025-01-28
- 財年截止
- 十二月
- 流通股數
- 24.28M
- CIK
- --
- 官方網址
- dmaacorp.com
Drugs Made In America Acquisition Corp.（DMAA）是一家特殊目的收購公司，致力透過與創新醫療企業建立策略合作夥伴關係，推動美國製藥業變革。DMAA專注於支持本土藥物生產並降低供應鏈風險，旨在提升美國消費者獲取藥物的便利性和可負擔性。透過運用先進技術並推動本地製造，DMAA有望顯著影響美國藥物可及性的格局。
財務指標
營業收入
2026-06-30
$0
2026-03-31
$0
2025-12-31
$0
2025-09-30
$0
營業支出
2026-06-30
$136.93K
2026-03-31
$143.3K
2025-12-31
$2.08M
2025-09-30
$263.7K
淨利潤
2026-06-30
$1.72M
2026-03-31
$1.97M
2025-12-31
$212.95K
2025-09-30
$2.18M
淨利潤率
2026-06-30
--
2026-03-31
--
2025-12-31
--
2025-09-30
--
每股收益
2026-06-30
$0.05
2026-03-31
$0.05
2025-12-31
$0.00
2025-09-30
$0.06
息稅折舊攤銷前利潤
2026-06-30
-$136.93K
2026-03-31
-$143.3K
2025-12-31
-$2.08M
2025-09-30
-$263.7K
有效稅率
2026-06-30
--
2026-03-31
--
2025-12-31
--
2025-09-30
--
| 項目 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
| 營業收入 | $0 | $0 | $0 | $0 |
| 營業支出 | $136.93K | $143.3K | $2.08M | $263.7K |
| 淨利潤 | $1.72M | $1.97M | $212.95K | $2.18M |
| 淨利潤率 | -- | -- | -- | -- |
| 每股收益 | $0.05 | $0.05 | $0.00 | $0.06 |
| 息稅折舊攤銷前利潤 | -$136.93K | -$143.3K | -$2.08M | -$263.7K |
| 有效稅率 | -- | -- | -- | -- |
常見問題
風險提示
股價可能大幅波動，短時間內可能出現顯著漲跌。 數位資產與衍生性商品交易可能涉及槓桿、流動性等額外風險。 本頁內容僅供參考，不構成任何投資建議。 產品可用性與訪問可能因地區及適用法規而異。